Actions

Emerging strategies and options: Difference between revisions

From MalariaETC

No edit summary
No edit summary
Line 9: Line 9:




<span style="font-size:90%">Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:</br>(a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, tests may be compiled the identify each with specificity -  ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH). This can offer some advantages in detecting dual infection by the two species when compared to using a pan-malarial antibody.
<span style="font-size:90%">'''Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:'''</br></br>(a) Where both ''P.falciparum'' and ''P.vivax'' are highly prevalent, tests may be compiled the identify each with specificity -  ''P.falciparum'' (HRP2) and ''P.vivax'' (Pv-pLDH). This can offer some advantages in detecting dual infection by the two species when compared to using a pan-malarial antibody.




to distinguish between infections by P. falciparum and P. vivax.  
to distinguish between infections by P. falciparum and P. vivax.  
Alternatively, tests can be multiplexed to select for Pf-pLDH and HRP2, which yields highly sensitive indications for falciparum malaria. [16] Multiplexed RDTs have also proven to be efficacious in discriminating between distinct diseases with non-specific symptomatic presentations.
Alternatively, tests can be multiplexed to select for Pf-pLDH and HRP2, which yields highly sensitive indications for falciparum malaria. [16] Multiplexed RDTs have also proven to be efficacious in discriminating between distinct diseases with non-specific symptomatic presentations.

Revision as of 14:37, 13 September 2024


Navigation
Go Back



Emerging Strategies


Multiplexed detection strategies may be used in some circumstances to optimase performance for local need:

(a) Where both P.falciparum and P.vivax are highly prevalent, tests may be compiled the identify each with specificity - P.falciparum (HRP2) and P.vivax (Pv-pLDH). This can offer some advantages in detecting dual infection by the two species when compared to using a pan-malarial antibody.


to distinguish between infections by P. falciparum and P. vivax. Alternatively, tests can be multiplexed to select for Pf-pLDH and HRP2, which yields highly sensitive indications for falciparum malaria. [16] Multiplexed RDTs have also proven to be efficacious in discriminating between distinct diseases with non-specific symptomatic presentations.